Posting of UK Annual Report and Accounts & Notice of AGM
Apr 17, 2018 06:00 am UTC| Business
NEW YORK, April 17, 2018 -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that its 2017 UK Annual Report and Accounts...
International network of law firms innovating with HighQ
Apr 17, 2018 06:00 am UTC| Business
LONDON, April 17, 2018 -- HighQ is pleased to announce that Ius Laboris, the leading international HR law Alliance, has adopted HighQ’s technology to enhance the value-adding services its member firms around the world...
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Apr 17, 2018 05:16 am UTC| Business
Basel, Switzerland, April 17, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into a license agreement with ArQule, Inc. (NASDAQ: ARQL) for its oncology drug candidate ARQ 087...
Apr 17, 2018 05:01 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 17 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
INNATE PHARMA : AACR 2018, New preclinical data further support ongoing programs
Apr 17, 2018 05:01 am UTC| Business
new preclinical data further support ongoing programs and highlight next generation of immunotherapies Next generation of immunotherapies presented by Chief Scientific Officer Eric Vivier in a meet-the-expert...
Apr 17, 2018 05:01 am UTC| Business
WISeKey International Holding Ltd Announces Date of the 2018 Annual General Meeting and Key Agenda Items Zug, Switzerland, April 17, 2018 - WISeKey International Holding Ltd ("WISeKey" or the "Company") (SIX: WIHN), a...
Apr 17, 2018 05:00 am UTC| Business
LRRACH, Germany and SAINT LOUIS, France, April 17, 2018 -- Allecra Therapeutics (Private), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening...